Journal Club: All Recent News

EU to set new biosimilar drug rules by mid-year

(Jan 6 2012)

Baxter, Momenta enter deal for biosimilar drugs

(Dec 22 2011)

Baxter and Momenta Announce Collaboration to Develop and Commercialize Follow-On Biologics

(Dec 22 2011)

Amgen, Watson to collaborate on oncology biosimilars

(Dec 19 2011)

Kymos, a Catalan Company, Signs a Collaboration Agreement With the Pharmaceutical Group Ipsen

(Dec 14 2011)

GE Healthcare and M+W Group Form Strategic Alliance in Vaccines, Insulin and Biopharmaceuticals

(Dec 13 2011)

PhRMA Statement on Biosimilar User Fees

(Dec 8 2011)

Biogen Idec, Samsung create biosimilars joint venture

(Dec 5 2011)

Amgen announces US patent issued for Enbrel

(Nov 23 2011)

Transgene Biotek to sell bio-generic product to German company for Rs 26 crore

(Nov 23 2011)

Fujifilm and Kyowa Hakko Kirin to set up a joint venture for the development of biosimilars

(Nov 15 2011)

Natco Pharma up 14%; to source and sell bio-generics products in India

(Oct 18 2011)

Merck & Co. Fine-Tunes Biosimilars Strategy as FDA Guidelines Loom

(Oct 5 2011)

Boehringer Ingelheim expands its Business with Biosimilars

(Sep 26 2011)

FDA set to issue guidelines on biosimilars

(Sep 23 2011)

Hospira Announces Positive Results From Phase I U.S. Clinical Trial of Biosimilar Erythropoietin in Renal Patients

(Sep 6 2011)

FDA: Generic biotech drugs require paradigm shift

(Aug 4 2011)

Pages